ATE432942T1 - Löslicher heterodimerer cytokinrezeptor - Google Patents

Löslicher heterodimerer cytokinrezeptor

Info

Publication number
ATE432942T1
ATE432942T1 AT02713823T AT02713823T ATE432942T1 AT E432942 T1 ATE432942 T1 AT E432942T1 AT 02713823 T AT02713823 T AT 02713823T AT 02713823 T AT02713823 T AT 02713823T AT E432942 T1 ATE432942 T1 AT E432942T1
Authority
AT
Austria
Prior art keywords
cytokine receptor
heterodimeric cytokine
soluble heterodimeric
immunoglobulin
subunit
Prior art date
Application number
AT02713823T
Other languages
English (en)
Inventor
Yasmin Chandrasekher
Julia Novak
Donald Foster
Wenfeng Xu
Stephen Jaspers
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Application granted granted Critical
Publication of ATE432942T1 publication Critical patent/ATE432942T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT02713823T 2001-03-09 2002-03-07 Löslicher heterodimerer cytokinrezeptor ATE432942T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27456001P 2001-03-09 2001-03-09
US29986501P 2001-06-21 2001-06-21
PCT/US2002/007214 WO2002072607A2 (en) 2001-03-09 2002-03-07 Soluble heterodimeric cytokine receptor

Publications (1)

Publication Number Publication Date
ATE432942T1 true ATE432942T1 (de) 2009-06-15

Family

ID=26956904

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02713823T ATE432942T1 (de) 2001-03-09 2002-03-07 Löslicher heterodimerer cytokinrezeptor

Country Status (11)

Country Link
EP (1) EP1399472B1 (de)
JP (1) JP4009535B2 (de)
AT (1) ATE432942T1 (de)
AU (1) AU2002245652A1 (de)
CA (1) CA2440596C (de)
DE (1) DE60232511D1 (de)
DK (1) DK1399472T3 (de)
EA (1) EA005496B1 (de)
ES (1) ES2327821T3 (de)
IL (2) IL157726A0 (de)
WO (1) WO2002072607A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003534773A (ja) 1999-12-03 2003-11-25 ザイモジェネティクス，インコーポレイティド ヒトサイトカイン受容体
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
US20030170823A1 (en) 1999-12-23 2003-09-11 Presnell Scott R. Novel cytokine ZCYTO18
US20030023033A1 (en) * 2001-07-26 2003-01-30 Laure Dumoutier Novel class II cytokine receptors and uses thereof
ES2381650T3 (es) 2000-08-08 2012-05-30 Zymogenetics, Inc. Receptores de citoquinas Zcytor11 solubles
EP1803733B1 (de) 2000-09-15 2010-03-10 ZymoGenetics, Inc. Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB
CA2439961A1 (en) 2001-03-27 2002-10-03 Zymogenetics, Inc. Human cytokine receptor
AU2012216499B2 (en) * 2001-10-19 2015-05-28 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
ATE384783T1 (de) 2001-10-19 2008-02-15 Zymogenetics Inc Dimerisierter wachstumsfaktor sowie materialien und verfahren zu seiner herstellung
IL161978A0 (en) 2001-12-17 2005-11-20 Zymogenetics Inc Method for treating cervical cancer
JP2005523001A (ja) 2002-02-11 2005-08-04 ザイモジェネティクス，インコーポレイティド 二量体増殖因子を調製するための材料と方法
CA2480163A1 (en) 2002-03-22 2003-10-09 Zymogenetics, Inc. Anti-il-tif antibodies and methods of using in inflammation
KR20110091598A (ko) * 2003-03-24 2011-08-11 지모제넥틱스, 인코포레이티드 항-ｉｌ-22ｒａ 항체 및 결합 파트너 및 염증에 있어서의 사용 방법
EP2087905A2 (de) 2003-08-08 2009-08-12 Novo Nordisk A/S Interleukin-20 zur Behandlung und Diagnose von mit Neovaskularization verbunden Zuständen
EP2143733A1 (de) 2003-11-21 2010-01-13 ZymoGenetics, Inc. Anti-il-20-Rezeptor-Antikörper und Bindungspartner und Verfahren zur Anwendung bei Entzündungen
PT1812476E (pt) 2004-10-22 2010-11-08 Zymogenetics Inc Anticorpos anti-il-22ra e parceiros de ligação e métodos de utilização no tratamento de inflamações
AU2006212807A1 (en) 2005-02-08 2006-08-17 Zymogenetics, Inc. Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
US20070054360A1 (en) 2005-05-12 2007-03-08 Zeren Gao Compositions and methods for modulating immune responses
CA2789061A1 (en) 2010-02-26 2011-09-01 Henrik Parshad Stable antibody containing compositions
CA2800188A1 (en) 2010-05-28 2011-12-01 Novo Nordisk A/S Stable multi-dose compositions comprising an antibody and a preservative
SI3151921T1 (sl) 2014-06-06 2019-12-31 Bristol-Myers Squibb Company Protitelesa proti z glukortikoidom induciranim receptorjem za faktor nekroze tumorja(GITR) in njihova uporaba
CN107743586B (zh) 2015-06-03 2021-07-02 百时美施贵宝公司 用于癌症诊断的抗gitr抗体
GB201514875D0 (en) * 2015-08-20 2015-10-07 Autolus Ltd Receptor
MX2018006072A (es) 2015-11-19 2018-08-01 Squibb Bristol Myers Co Anticuerpos contra receptor de factor de necrosis de tumor inducido por glucocorticoides (gitr) y usos de los mismos.
CN110869392A (zh) 2017-05-16 2020-03-06 百时美施贵宝公司 用抗gitr激动性抗体治疗癌症

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965704A (en) * 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
AU2222700A (en) * 1998-12-31 2000-07-31 Millennium Pharmaceuticals, Inc. Class ii cytokine receptor-like proteins and nucleic acids encoding them

Also Published As

Publication number Publication date
EP1399472B1 (de) 2009-06-03
WO2002072607A3 (en) 2004-01-15
AU2002245652A1 (en) 2002-09-24
JP4009535B2 (ja) 2007-11-14
CA2440596A1 (en) 2002-09-19
CA2440596C (en) 2011-05-24
EA005496B1 (ru) 2005-02-24
EA200300983A1 (ru) 2004-06-24
EP1399472A2 (de) 2004-03-24
IL204299A (en) 2011-06-30
ES2327821T3 (es) 2009-11-04
DE60232511D1 (de) 2009-07-16
WO2002072607A2 (en) 2002-09-19
JP2004536040A (ja) 2004-12-02
DK1399472T3 (da) 2009-10-05
EP1399472A4 (de) 2004-06-30
IL157726A0 (en) 2004-03-28

Similar Documents

Publication Publication Date Title
ATE432942T1 (de) Löslicher heterodimerer cytokinrezeptor
DE60040240D1 (de) Löslicher interleukin-20 rezeptor
CY1112787T1 (el) Πολλαπλομερη του υποδοχεα κυτοκινης ζcytor17
NO20050685L (no) NOGO-reseptorantagonister
TW200732350A (en) Methods for generating monovalent IgG
CY1106594T1 (el) Αντισωματα εναντι ανθρωπινης il-12
ATE374042T1 (de) Fc-fusionsproteine zur erhöhung der immunogenität von protein- und peptid-antigenen
ATE490969T1 (de) Modifizierte transferrin-fusionsproteine
IS5217A (is) Bræðsluprótín á föstu svæði úr beta-breytivaxtarþætti (TGF-beta) af gerð II og ónæmisglóbúlíni
DK1140173T3 (da) Vaskulære endothelcellevækstfaktorantagonister og anvendelser deraf
DE60333306D1 (de) Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen
DK1691833T3 (da) Præparater der omfatter polypeptider
CY1112840T1 (el) Πρωτεϊνες συντηξης ταci-ανοσοσφαιρινης
EA200400384A1 (ru) Растворимый рецептор т-клетки

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1399472

Country of ref document: EP